Septicemic Plague: Infection of the Blood

Septicemic plague is the least common but most rapidly fatal form of plague. It occurs when Yersinia pestis bacteria multiply massively in the bloodstream, overwhelming the body’s defences and causing disseminated intravascular coagulation, tissue necrosis, and circulatory collapse. During the Black Death, septicemic plague contributed to the pandemic’s extraordinary lethality, killing victims so rapidly that they sometimes died before the characteristic buboes of bubonic plague had time to develop.

Pathogenesis

Septicemic plague can arise in three ways. Primary septicemic plague occurs when bacteria enter the bloodstream directly, typically through a flea bite that bypasses the lymphatic system or through a break in the skin. Secondary septicemic plague develops as a complication of bubonic or pneumonic plague, when bacteria that have multiplied in the lymph nodes or lungs enter the bloodstream and multiply uncontrollably. In all cases, the result is the same: an overwhelming bacterial infection of the blood that triggers a cascade of pathological events.

Once in the bloodstream, Yersinia pestis multiplies rapidly, reaching concentrations of millions of bacteria per millilitre of blood. The bacteria release endotoxins and other virulence factors that trigger a massive inflammatory response. The body’s coagulation system is activated, causing the formation of tiny blood clots throughout the circulatory system (disseminated intravascular coagulation, or DIC). These clots consume the body’s supply of clotting factors, leading paradoxically to uncontrolled bleeding in other parts of the body.

The combination of clotting and bleeding, together with the direct toxic effects of the bacteria, causes widespread tissue damage. The extremities — fingers, toes, nose, ears — are particularly vulnerable, as the small blood vessels that supply them are blocked by clots or destroyed by inflammation. The resulting tissue death (necrosis) produces the dark, gangrenous patches that gave the Black Death its name.

Symptoms and Clinical Course

The symptoms of septicemic plague are severe and rapidly progressive. The patient develops a high fever, chills, extreme weakness, abdominal pain, and shock. Unlike bubonic plague, septicemic plague may not produce visible buboes, making diagnosis more difficult. The absence of the characteristic swellings may have confused medieval physicians, who relied on buboes as the primary diagnostic sign.

As the disease progresses, the patient develops bleeding manifestations: bruising (ecchymoses), bleeding from the nose and mouth, blood in the urine and stool, and the characteristic dark patches on the skin caused by subcutaneous haemorrhage and tissue necrosis. The fingers, toes, and other extremities may turn black and gangrenous as their blood supply is cut off by disseminated intravascular coagulation.

The speed of septicemic plague is its most terrifying feature. Patients may die within hours of the onset of symptoms, sometimes before they or their physicians recognise the nature of the illness. The mortality rate of untreated septicemic plague approaches one hundred percent. Even with modern antibiotic treatment, the mortality rate remains high — approximately forty percent — because the disease progresses so rapidly that treatment is often initiated too late.

Septicemic Plague During the Black Death

The role of septicemic plague in the Black Death is difficult to quantify precisely, as medieval sources did not distinguish between the different clinical forms of the disease. However, several features of contemporary descriptions are consistent with septicemic plague.

The dark patches on the skin — variously described as “tokens,” “spots,” “blotches,” or “God’s marks” — that are mentioned in many contemporary accounts of the Black Death are characteristic of the subcutaneous haemorrhage and tissue necrosis caused by septicemic plague. The Italian chronicler Marchionne di Coppo Stefani described victims who developed “certain spots, black or livid, on the thighs or arms” — a description consistent with the purpuric lesions of disseminated intravascular coagulation.

The rapidity of death described in some accounts — victims who were healthy in the morning and dead by evening — is also consistent with septicemic plague. While pneumonic plague can also kill rapidly, the absence of respiratory symptoms (coughing, spitting of blood) in some of these accounts suggests that septicemic plague was responsible.

The name “Black Death” itself may derive from the dark patches of necrotic skin that appear in septicemic plague patients. The term was not used during the fourteenth century — contemporaries called the pandemic the “great mortality,” the “great pestilence,” or simply “the plague” — but it was coined in later centuries, possibly in reference to the dark discoloration of the body that characterised the most severe cases.

The Contribution to Overall Mortality

Septicemic plague, while less common than bubonic plague, contributed significantly to the overall mortality of the Black Death. Its near-universal fatality rate meant that every case of septicemic plague was a death, and its rapid progression left no time for treatment or recovery. In a pandemic that already involved the co-circulation of bubonic and pneumonic plague, the addition of septicemic plague further increased the overall death rate.

The relative contribution of each clinical form to the total mortality of the Black Death is debated. The epidemiologist Ole Benedictow has estimated that bubonic plague accounted for the majority of cases and deaths, with pneumonic and septicemic plague contributing a significant minority. Other scholars have argued for a larger role for pneumonic and septicemic forms, particularly in the winter months and in communities where rat and flea populations were small.

Septicemic Plague in Modern Medicine

In the modern era, septicemic plague remains a medical emergency requiring immediate antibiotic treatment. The standard regimen includes streptomycin or gentamicin, supplemented by doxycycline or ciprofloxacin. Supportive care — intravenous fluids, vasopressors, and management of disseminated intravascular coagulation — is also essential. Even with optimal treatment, the mortality rate remains significant, reflecting the severity of the underlying infection.

The modern understanding of septicemic plague, based on advances in bacteriology, immunology, and critical care medicine, has revealed the mechanisms by which Yersinia pestis causes disseminated intravascular coagulation and multi-organ failure. This understanding has informed the development of treatment protocols that, while not eliminating the disease’s lethality, have significantly improved survival rates compared to the pre-antibiotic era.